Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist
about
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@ast
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@en
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@nl
type
label
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@ast
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@en
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@nl
prefLabel
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@ast
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@en
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@nl
P2093
P2860
P356
P1476
Preclinical pharmacology and p ...... -aspartate receptor antagonist
@en
P2093
Armando Lagrutta
Blake M Paterson
Christine Fandozzi
James J Vornov
John A McCauley
Joseph J Lynch
Laszlo Kiss
Nigel J Liverton
Rachel Garner
Reza Mazhari
P2860
P304
P356
10.1002/PRP2.198
P407
P577
2015-12-01T00:00:00Z